Biocompatibles Share Discussion Threads

[robin_of_loxley] 12/2/2007 13:28

Tratante,

cheers for the pointer

Header updated a little, similar to how I do the rest of my headers these days.

What do you see as a target price, and over what time frame? sensible answers only please ;-)

regards,

RoL
>>>>------------------>

[blackbear] 12/2/2007 12:43

Sold a quarter of holding for which i paid 129, see how she goes from here.

[tratante] 12/2/2007 12:29

Bound to be some sellers along the way but medium term it looks good.

[blackbear] 12/2/2007 08:45

Progressing well again this morning im sure some seller will come to the surface at some point.

[lennox_lnx_multibagg] 11/2/2007 23:58

LENNOX IS SET TO ERUPT..PLEASE REVIEW THIS COMPANY

FACT: MARKET CAP.ONLY 0.3 MILLION.
FACT: SHARES IN ISSUE ONLY 24 MILLION.
FACT: OVERHANG NEARLY GONE. BUY LIMIT LAST WEEK WAS 500,000 @1.6P NOW ONLY 75000K @ 1.6P.
FACT: SELL LIMITED WAS 50,000 @ 1.09P AT THE START OF THE WEEK, NOW 250,000 @ 1.09P. MMS WANT CHEAP STOCK.
What does this mean? A few buys LNX will explode.

Last RNS
Lennox to carry out full review in difficult trading conditions; MD retires

FACT. The review is expected to be completed in early March.

FACT ANYTHING SLIGHTLY POSITIVE LNX WILL ERUPT.

PROJECTIONS ANYWERE FROM 200%-10000%

FACT. 500,000 SHARES BOUGHT AT A MID PRICE OF 1.5P IN THE LAST FORTNIGHT, A LOT FOR LNX.

OPINION: PRICE BEING HELD BACK AS BUYER ACCUMULATES.

OPINION: IF TRUE THEN IT REFUTES THE NOTION THAT LNX ARE GOING BUST.

OPINION: EVEN IF THEY ARE, WHAT A CHEAP SHELL TO GET YOURSELF LISTED ON AIM.

OPINION: BY APRIL LNX WILL BE 15P-60P


OPINION LNX ARE THE BEST BUY ON AIM TODAY FOR MULTIBAGGER REWARDS.

[blackbear] 09/2/2007 16:25

Only 34k traded how many does the buyer want.. could be going up in 10's a day soon.

[tratante] 09/2/2007 15:23

These shares are tightly held and only 21M in issue. Smallish buys make quite a big difference. Be good if we could finish the week above 150.

[blackbear] 09/2/2007 13:49

Looks like the Sp is heating up now.

[tratante] 08/2/2007 13:36

well I know nothing about XEN, but BII are not about to hit the buffers. They have leading products on sale in ever increasing markets, they have exciting things in development and progress with those is looking good on several fronts. They also have a lot of cash (£37M) in the bank. DYOR

[prallum] 08/2/2007 13:28

IC said XEN were good value just before XEN hit the buffers.

[tratante] 08/2/2007 11:04

Yes looked like its was building up yesterday. Be nice it recovered as fast as it fell a couple of months ago!

[blackbear] 08/2/2007 08:45

Some sort of breakout forming on the chart.

[tratante] 07/2/2007 10:36

Lots of small sells over recent days mopped up by a few large buys. Someone accumulating?

[tratante] 29/1/2007 22:24

LOL - they do sometimes get it right by chance!

[scribbler101] 28/1/2007 18:47

Apparently BII mentioned in IC today as "good value".


SELL SELL SELL

[tratante] 26/1/2007 09:33

Only what you can read in the header and the posts above. DYOR but I think these are cheap anywhere under £2.

[kallista] 26/1/2007 07:49

Apparently BII mentioned in IC today as "good value". Anyone further info?

[blackbear] 25/1/2007 15:35

Is this in a breakout chart wise.. maybe 140p was considered a barrier.

[tratante] 25/1/2007 07:05

There is also great potential in the bead block treatment for uterine fibroids. This condition does not have the mortality of liver cancer, but consider the benefits to patient, health service, and the economy of obviating the need for a hysterectomy and the subsequent often lengthy recovery time.

[oharebj] 24/1/2007 23:16

RE the latest phase 11 trial results.

Colorectal cancer is the 3rd commonest cancer in the western world. With our ageing populations the incidence is rising. Many of the deaths are due to spread to the liver because to date, there was no effective treatment.

In the control group patients were given TLC (tender loving care) and 73% died within the study time frame.

In the treated group only 13% died - quite a staggering difference, even allowing for small numbers. Most patients reported an improvement in quality of life as well, meaning that the treatment is well-tolerated.

The potential of this treatment is stunning and the market size is absolutely huge.

[tratante] 23/1/2007 08:16

I wonder if people still see this as a stent dependent company, which is why the fall following the Abbott news was so dramatic. In my view it was seriously overdone, the bead technologies are the key to bii.

[oharebj] 22/1/2007 17:50

I have some experience working in the field - this trading statement is quite phenomonal. Obviously stage 111 trials will be required but colorectal CA with liver mets is very common and treatments to date have been largely ineffective. The potential market is extremely large

[plutonian] 22/1/2007 14:12

* Drug Eluting Beads at ASCO GI
* Positive Comparative Data in Metastatic Colorectal Cancer

[tratante] 21/1/2007 17:40

Am I right that if BII have 37 million shares in issue and 37 million in cash, the rest of the company is worth 20p? Must be some upside here I would have thought.